Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 226 of 226 entries
Sorted by: Best Match Show Resources per page
IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery.

Cell reports. Medicine

Faramia J, Hao Z, Mumphrey MB, Townsend RL, Miard S, Carreau AM, Nadeau M, Frisch F, Baraboi ED, Grenier-Larouche T, Noll C, Li M, Biertho L, Marceau S, Hould FS, Lebel S, Morrison CD, Münzberg H, Richard D, Carpentier AC, Tchernof A, Berthoud HR, Picard F.
PMID: 33948578
Cell Rep Med. 2021 Apr 20;2(4):100248. doi: 10.1016/j.xcrm.2021.100248. eCollection 2021 Apr 20.

Insulin-like growth factor-binding protein (IGFBP)-2 is a circulating biomarker of cardiometabolic health. Here, we report that circulating IGFBP-2 concentrations robustly increase after different bariatric procedures in humans, reaching higher levels after biliopancreatic diversion with duodenal switch (BPD-DS) than after...

Cite
Faramia J, Hao Z, Mumphrey MB, et al. IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell Rep Med. 2021;2(4):100248doi: 10.1016/j.xcrm.2021.100248.
Faramia, J., Hao, Z., Mumphrey, M. B., Townsend, R. L., Miard, S., Carreau, A. M., Nadeau, M., Frisch, F., Baraboi, E. D., Grenier-Larouche, T., Noll, C., Li, M., Biertho, L., Marceau, S., Hould, F. S., Lebel, S., Morrison, C. D., Münzberg, H., Richard, D., Carpentier, A. C., Tchernof, A., Berthoud, H. R., & Picard, F. (2021). IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell reports. Medicine, 2(4), 100248. https://doi.org/10.1016/j.xcrm.2021.100248
Faramia, Justine, et al. "IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery." Cell reports. Medicine vol. 2,4 (2021): 100248. doi: https://doi.org/10.1016/j.xcrm.2021.100248
Faramia J, Hao Z, Mumphrey MB, Townsend RL, Miard S, Carreau AM, Nadeau M, Frisch F, Baraboi ED, Grenier-Larouche T, Noll C, Li M, Biertho L, Marceau S, Hould FS, Lebel S, Morrison CD, Münzberg H, Richard D, Carpentier AC, Tchernof A, Berthoud HR, Picard F. IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery. Cell Rep Med. 2021 Apr 20;2(4):100248. doi: 10.1016/j.xcrm.2021.100248. eCollection 2021 Apr 20. PMID: 33948578; PMCID: PMC8080239.
Copy Download .nbib Format: NLM
Does Trust Always Help Gender Role Attitudes? The Role of Individualism and Collectivism.

Social indicators research

Dutta N, Giddings L, Sobel RS.
PMID: 34276121
Soc Indic Res. 2021 Jul 10;1-30. doi: 10.1007/s11205-021-02755-y. Epub 2021 Jul 10.

Social trust has a complex interrelationship with attitudes toward gender equality. Social trust has its origins in exchange relationships in preindustrial societies, lowering uncertainty in transactions and easing interpersonal exchanges. The degree to which this trust was extended to...

Cite
Dutta N, Giddings L, Sobel RS. Does Trust Always Help Gender Role Attitudes? The Role of Individualism and Collectivism. Soc Indic Res. 2021;1-30doi: 10.1007/s11205-021-02755-y.
Dutta, N., Giddings, L., & Sobel, R. S. (2021). Does Trust Always Help Gender Role Attitudes? The Role of Individualism and Collectivism. Social indicators research, 1-30. https://doi.org/10.1007/s11205-021-02755-y
Dutta, Nabamita, et al. "Does Trust Always Help Gender Role Attitudes? The Role of Individualism and Collectivism." Social indicators research vol. (2021): 1-30. doi: https://doi.org/10.1007/s11205-021-02755-y
Dutta N, Giddings L, Sobel RS. Does Trust Always Help Gender Role Attitudes? The Role of Individualism and Collectivism. Soc Indic Res. 2021 Jul 10;1-30. doi: 10.1007/s11205-021-02755-y. Epub 2021 Jul 10. PMID: 34276121; PMCID: PMC8270773.
Copy Download .nbib Format: NLM
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL.

Circulation

Marston NA, Giugliano RP, Park JG, Ruzza A, Sever PS, Keech AC, Sabatine MS.
PMID: 34452583
Circulation. 2021 Nov 23;144(21):1732-1734. doi: 10.1161/CIRCULATIONAHA.121.056536. Epub 2021 Aug 27.

No abstract available.

Cite
Marston NA, Giugliano RP, Park JG, et al. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation. 2021;144(21):1732-1734doi: 10.1161/CIRCULATIONAHA.121.056536.
Marston, N. A., Giugliano, R. P., Park, J. G., Ruzza, A., Sever, P. S., Keech, A. C., & Sabatine, M. S. (2021). Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation, 144(21), 1732-1734. https://doi.org/10.1161/CIRCULATIONAHA.121.056536
Marston, Nicholas A, et al. "Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL." Circulation vol. 144,21 (2021): 1732-1734. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056536
Marston NA, Giugliano RP, Park JG, Ruzza A, Sever PS, Keech AC, Sabatine MS. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation. 2021 Nov 23;144(21):1732-1734. doi: 10.1161/CIRCULATIONAHA.121.056536. Epub 2021 Aug 27. PMID: 34452583; PMCID: PMC8608715.
Copy Download .nbib Format: NLM
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.

Circulation journal : official journal of the Japanese Circulation Society

Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine MS.
PMID: 33980763
Circ J. 2021 Oct 25;85(11):2063-2070. doi: 10.1253/circj.CJ-20-1051. Epub 2021 May 15.

BACKGROUND: There are concerns that Asian patients respond differently to some medications. This study evaluated the efficacy and safety of evolocumab among Asian vs. other subjects in the FOURIER trial, which randomized stable atherosclerosis patients to receive either evolocumab...

Cite
Keech AC, Oyama K, Sever PS, et al. Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. Circ J. 2021;85(11):2063-2070doi: 10.1253/circj.CJ-20-1051.
Keech, A. C., Oyama, K., Sever, P. S., Tang, M., Murphy, S. A., Hirayama, A., Lu, C., Tay, L., Deedwania, P. C., Siu, C. W., Lira Pineda, A., Choi, D., Charng, M. J., Amerena, J., Wan Ahmad, W. A., Chopra, V. K., Pedersen, T. R., Giugliano, R. P., Sabatine, M. S. (2021). Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. Circulation journal : official journal of the Japanese Circulation Society, 85(11), 2063-2070. https://doi.org/10.1253/circj.CJ-20-1051
Keech, Anthony C, et al. "Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial." Circulation journal : official journal of the Japanese Circulation Society vol. 85,11 (2021): 2063-2070. doi: https://doi.org/10.1253/circj.CJ-20-1051
Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine MS. Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. Circ J. 2021 Oct 25;85(11):2063-2070. doi: 10.1253/circj.CJ-20-1051. Epub 2021 May 15. PMID: 33980763.
Copy Download .nbib Format: NLM
Echolocating Daubenton's bats are resilient to broadband, ultrasonic masking noise during active target approaches.

The Journal of experimental biology

Foskolos I, Pedersen MB, Beedholm K, Uebel AS, Macaulay J, Stidsholt L, Brinkløv S, Madsen PT.
PMID: 35037031
J Exp Biol. 2022 Jan 17; doi: 10.1242/jeb.242957. Epub 2022 Jan 17.

Echolocating bats hunt prey on the wing under conditions of poor lighting by emission of loud calls and subsequent auditory processing of weak returning echoes. To do so, they need adequate echo-to-noise ratios (ENRs) to detect and distinguish target...

Cite
Foskolos I, Pedersen MB, Beedholm K, et al. Echolocating Daubenton's bats are resilient to broadband, ultrasonic masking noise during active target approaches. J Exp Biol. 2022;doi: 10.1242/jeb.242957.
Foskolos, I., Pedersen, M. B., Beedholm, K., Uebel, A. S., Macaulay, J., Stidsholt, L., Brinkløv, S., & Madsen, P. T. (2022). Echolocating Daubenton's bats are resilient to broadband, ultrasonic masking noise during active target approaches. The Journal of experimental biology, . https://doi.org/10.1242/jeb.242957
Foskolos, Ilias, et al. "Echolocating Daubenton's bats are resilient to broadband, ultrasonic masking noise during active target approaches." The Journal of experimental biology vol. (2022). doi: https://doi.org/10.1242/jeb.242957
Foskolos I, Pedersen MB, Beedholm K, Uebel AS, Macaulay J, Stidsholt L, Brinkløv S, Madsen PT. Echolocating Daubenton's bats are resilient to broadband, ultrasonic masking noise during active target approaches. J Exp Biol. 2022 Jan 17; doi: 10.1242/jeb.242957. Epub 2022 Jan 17. PMID: 35037031.
Copy Download .nbib Format: NLM
Sleep and Physical Performance: A Case Study of Collegiate Women's Division 1 Basketball Players.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Taber C, Senbel S, Ezzeddine D, Nolan J, Ocel A, Artan NS, Kaya T.
PMID: 34892666
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:6787-6790. doi: 10.1109/EMBC46164.2021.9630820.

In this work, we present a case study to evaluate the connections between sleep, training load, and the perceptions of physical/emotional state of a collegiate, division 1 Women's basketball team. The study took place during the off- (3 weeks)...

Cite
Taber C, Senbel S, Ezzeddine D, et al. Sleep and Physical Performance: A Case Study of Collegiate Women's Division 1 Basketball Players. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:6787-6790doi: 10.1109/EMBC46164.2021.9630820.
Taber, C., Senbel, S., Ezzeddine, D., Nolan, J., Ocel, A., Artan, N. S., & Kaya, T. (2021). Sleep and Physical Performance: A Case Study of Collegiate Women's Division 1 Basketball Players. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20216787-6790. https://doi.org/10.1109/EMBC46164.2021.9630820
Taber, C, et al. "Sleep and Physical Performance: A Case Study of Collegiate Women's Division 1 Basketball Players." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 6787-6790. doi: https://doi.org/10.1109/EMBC46164.2021.9630820
Taber C, Senbel S, Ezzeddine D, Nolan J, Ocel A, Artan NS, Kaya T. Sleep and Physical Performance: A Case Study of Collegiate Women's Division 1 Basketball Players. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:6787-6790. doi: 10.1109/EMBC46164.2021.9630820. PMID: 34892666.
Copy Download .nbib Format: NLM
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL.

Circulation

Marston NA, Giugliano RP, Park JG, Ruzza A, Sever PS, Keech AC, Sabatine MS.
PMID: 34452583
Circulation. 2021 Nov 23;144(21):1732-1734. doi: 10.1161/CIRCULATIONAHA.121.056536. Epub 2021 Aug 27.

No abstract available.

Cite
Marston NA, Giugliano RP, Park JG, et al. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation. 2021;144(21):1732-1734doi: 10.1161/CIRCULATIONAHA.121.056536.
Marston, N. A., Giugliano, R. P., Park, J. G., Ruzza, A., Sever, P. S., Keech, A. C., & Sabatine, M. S. (2021). Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation, 144(21), 1732-1734. https://doi.org/10.1161/CIRCULATIONAHA.121.056536
Marston, Nicholas A, et al. "Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL." Circulation vol. 144,21 (2021): 1732-1734. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056536
Marston NA, Giugliano RP, Park JG, Ruzza A, Sever PS, Keech AC, Sabatine MS. Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL. Circulation. 2021 Nov 23;144(21):1732-1734. doi: 10.1161/CIRCULATIONAHA.121.056536. Epub 2021 Aug 27. PMID: 34452583; PMCID: PMC8608715.
Copy Download .nbib Format: NLM
Influence of comfort and social stimuli on a comfort movement and a display derived from it.

Animal behaviour

Sebbel P, DÜTTMANN H, Groothuis T.
PMID: 9480679
Anim Behav. 1998 Jan;55(1):129-37. doi: 10.1006/anbe.1997.0591.

We tested the extent of emancipation of the Whistle-shake display of male shelducks, Tadorna tadorna, from causal factors controlling its presumed evolutionary precursor, the Body-shake, a comfort movement. Both motor patterns show similarities in form and alternate in a...

Cite
Sebbel P, DÜTTMANN H, Groothuis T. Influence of comfort and social stimuli on a comfort movement and a display derived from it. Anim Behav. 1998;55(1):129-37doi: 10.1006/anbe.1997.0591.
Sebbel, P., DÜTTMANN, H., & Groothuis, T. (1998). Influence of comfort and social stimuli on a comfort movement and a display derived from it. Animal behaviour, 55(1), 129-37. https://doi.org/10.1006/anbe.1997.0591
Sebbel, et al. "Influence of comfort and social stimuli on a comfort movement and a display derived from it." Animal behaviour vol. 55,1 (1998): 129-37. doi: https://doi.org/10.1006/anbe.1997.0591
Sebbel P, DÜTTMANN H, Groothuis T. Influence of comfort and social stimuli on a comfort movement and a display derived from it. Anim Behav. 1998 Jan;55(1):129-37. doi: 10.1006/anbe.1997.0591. PMID: 9480679.
Copy Download .nbib Format: NLM
Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation.

International journal of cardiology. Heart & vasculature

Ebert M, Karrengarn R, Jahnke C, Kircher S, Oebel S, Döring M, Hindricks G, Paetsch I, Richter S.
PMID: 35024429
Int J Cardiol Heart Vasc. 2021 Dec 29;38:100939. doi: 10.1016/j.ijcha.2021.100939. eCollection 2022 Feb.

INTRODUCTION: Preprocedural cardiovascular magnetic resonance (CMR) or computed tomography (CT) imaging of the left atrium/pulmonary veins is usually employed to guide catheter ablation of atrial fibrillation (AFCA). Incidental findings (IFs) are common on cardiac imaging prior to AFCA. However,...

Cite
Ebert M, Karrengarn R, Jahnke C, et al. Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2021;38:100939doi: 10.1016/j.ijcha.2021.100939.
Ebert, M., Karrengarn, R., Jahnke, C., Kircher, S., Oebel, S., Döring, M., Hindricks, G., Paetsch, I., & Richter, S. (2022). Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. International journal of cardiology. Heart & vasculature, 38100939. https://doi.org/10.1016/j.ijcha.2021.100939
Ebert, Micaela, et al. "Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation." International journal of cardiology. Heart & vasculature vol. 38 (2022): 100939. doi: https://doi.org/10.1016/j.ijcha.2021.100939
Ebert M, Karrengarn R, Jahnke C, Kircher S, Oebel S, Döring M, Hindricks G, Paetsch I, Richter S. Major incidental findings on routine cardiovascular magnetic resonance imaging prior to first-time catheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2021 Dec 29;38:100939. doi: 10.1016/j.ijcha.2021.100939. eCollection 2022 Feb. PMID: 35024429; PMCID: PMC8728394.
Copy Download .nbib Format: NLM
Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy.

Circulation

Marston NA, Oyama K, Jarolim P, Tang M, Sever PS, Keech AC, Lira Pineda A, Wang H, Giugliano RP, Sabatine MS, Morrow DA.
PMID: 34279993
Circulation. 2021 Jul 20;144(3):249-251. doi: 10.1161/CIRCULATIONAHA.121.054663. Epub 2021 Jul 19.

No abstract available.

Cite
Marston NA, Oyama K, Jarolim P, et al. Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy. Circulation. 2021;144(3):249-251doi: 10.1161/CIRCULATIONAHA.121.054663.
Marston, N. A., Oyama, K., Jarolim, P., Tang, M., Sever, P. S., Keech, A. C., Lira Pineda, A., Wang, H., Giugliano, R. P., Sabatine, M. S., & Morrow, D. A. (2021). Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy. Circulation, 144(3), 249-251. https://doi.org/10.1161/CIRCULATIONAHA.121.054663
Marston, Nicholas A, et al. "Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy." Circulation vol. 144,3 (2021): 249-251. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.054663
Marston NA, Oyama K, Jarolim P, Tang M, Sever PS, Keech AC, Lira Pineda A, Wang H, Giugliano RP, Sabatine MS, Morrow DA. Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy. Circulation. 2021 Jul 20;144(3):249-251. doi: 10.1161/CIRCULATIONAHA.121.054663. Epub 2021 Jul 19. PMID: 34279993; PMCID: PMC8442603.
Copy Download .nbib Format: NLM
Showing 217 to 226 of 226 entries